Incorporated in 2017, Myriad Pharmaceuticals is a subsidiary of VEC Ltd, primarily responsible for providing technical support to our parent company, including 25 own-brand products designed and formulated by us.

Based in Auckland with a world-class manufacturing and laboratory facility, Myriad covers over 1000 sqm and features multiple cleanrooms and two large-scale packing lines. Our team of experts includes world-class pharmacists, chemists, designers, toxicologists, scientists, researchers, and industry professionals who work tirelessly to develop cutting-edge products and services that meet the evolving needs of our customers.

As leaders in developing and producing nicotine e-liquid and specialising in Electronic Nicotine Delivery Systems (ENDS), we understand the unique challenges of working with heavily regulated products and help clients navigate compliance and regulation testing.

We are committed to ensuring the safety and effectiveness of our products through a robust and stringent Quality Management System (QMS) under Good Manufacturing Practices (GMP). We use molecular design, biocompatibility and chemical compatibility approaches to achieve, with integrity and quality, safe and stable products for local and international markets. We also apply validated internal testing with defined laboratory protocols in adherence to GMP regulations.

At Myriad, we believe in using only the best ingredients to create high-performing products for ourselves and our clients. This is why we use certified natural and synthetic ingredients, ensuring the quality and safety of our products. Our New Product Development (NPD) team operates in a fully secure laboratory facility designed to surpass future regulatory scrutiny, further reinforcing our commitment to compliance and quality.